SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-20-024585
Filing Date
2020-08-31
Accepted
2020-08-31 16:26:58
Documents
15
Period of Report
2020-08-31
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea126228-8k_aikido.htm 8-K 29183
2 PRESENTATION, DATED AUGUST 31, 2020 ea126228ex99-1_aikido.htm EX-99.1 19568
3 GRAPHIC ex99-1_001.jpg GRAPHIC 104596
4 GRAPHIC ex99-1_002.jpg GRAPHIC 190595
5 GRAPHIC ex99-1_003.jpg GRAPHIC 321660
6 GRAPHIC ex99-1_004.jpg GRAPHIC 282990
7 GRAPHIC ex99-1_005.jpg GRAPHIC 240797
8 GRAPHIC ex99-1_006.jpg GRAPHIC 234071
9 GRAPHIC ex99-1_007.jpg GRAPHIC 287372
10 GRAPHIC ex99-1_008.jpg GRAPHIC 241782
11 GRAPHIC ex99-1_009.jpg GRAPHIC 260508
12 GRAPHIC ex99-1_010.jpg GRAPHIC 214134
13 GRAPHIC ex99-1_011.jpg GRAPHIC 161204
14 GRAPHIC ex99-1_012.jpg GRAPHIC 138138
15 GRAPHIC ex99-1_013.jpg GRAPHIC 84946
  Complete submission text file 0001213900-20-024585.txt   3856435
Mailing Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020
Business Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020 347-321-7646
Aikido Pharma Inc. (Filer) CIK: 0000012239 (see all company filings)

IRS No.: 520849320 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-05576 | Film No.: 201151801
SIC: 8731 Services-Commercial Physical & Biological Research